In recent years, the biotech industry has emerged as a cornerstone of innovation, especially in areas like gene therapy , personalized medicine , and vaccine development . However, this dynamic and promising sector is highly sensitive to government regulations , policy frameworks , and economic signals . Under the Trump administration , the biotech sector witnessed a turbulent journey, driven by policy uncertainty , sudden regulatory shifts, and volatile rhetoric on healthcare pricing reforms . This blog delves into how Trump’s policy ambiguity and decision-making style impacted the biotech industry, contributing to a market slump and investor hesitancy. It also analyzes the broader implications for pharmaceutical innovation , R&D funding , and global biotech partnerships . Trump Administration and Policy Volatility One of the defining features of Donald Trump’s presidency was his unconventional approach to governance . For sectors like biotech, which rely on predictable and ...

